CSE/IAN (CSE/IAN)

Canadian Securities Exchange: CSE/IAN · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	34.9M
Revenue (ttm)	197.6M
Net income (ttm)	-78.6M
EPS (ttm)	-CA$0.01
Shares out	7B
Volume	1,756
Beta	-0.67

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 197.6M
Net income (ttm): -78.6M
EPS (ttm): -CA$0.01
Market cap: 34.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROIC-5.3

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/IAN indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-13
Employees	792
Employees change	-42
Employees growth	-5.04%
Enterprise value	CAD 363M
Exchange	Canadian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA45074T1021
Last earnings date	2025-11-07
Last refreshed	2026-10-29
Market cap	CAD 34.9M
Next earnings date	2026-11-13
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	cse/IAN
Website	https://www.ianthus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-231.78%
EV/EBITDA	19.22x
EV/Sales	1.84x
FCF / EV yield	-8.77%
FCF yield	-91.23%
Industry forward P/E	34.4x
P/S ratio	0.18x
Price/EBITDA ratio	3.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-7.65%
EBITDA margin	4.69%
Gross margin	45.05%
Operating margin	-7.65%
Pretax margin	-23.32%
Profit margin	-39.79%
Profit per employee	CAD -106,111
Revenue per employee	CAD 266,655
ROA	-2.53%
ROA (5Y)	-5.57%
ROCE	51.36%
ROIC	-5.33%
SBC / revenue	1.3%
Tax / revenue	16.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-13.24%
Gross profit growth (Q)	-0.33%
Gross profit growth 3Y	-1.79%
Gross profit growth 5Y	-10.4%
Net income growth quarters	1
Net income growth years	0
OCF growth (Q)	-75.91%
OCF growth (QoQ)	-24.95%
Revenue growth	-10.76%
Revenue growth (Q)	0.47%
Revenue growth (QoQ)	5.49%
Revenue growth 10Y	123.09%
Revenue growth 3Y	-2.86%
Revenue growth 5Y	-6.3%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -29.9M
Depreciation and amortization	CAD 24M
EBIT	CAD -15.1M
EBITDA	CAD 9.3M
EPS	CAD -0.01
FCF per share	CAD -0.00
Financing cash flow	CAD -5.3M
Free cash flow	CAD -31.8M
Free cash flow minus SBC	CAD -34.4M
Gross profit	CAD 89M
Income taxes	CAD 32.6M
Investing cash flow	CAD -15M
Net borrowing	CAD -5M
Net cash flow	CAD -22.2M
Net income	CAD -78.6M
Operating cash flow minus SBC	CAD -4.5M
Operating income	CAD -15.1M
Revenue	CAD 197.6M
Stock-based compensation	CAD 2.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-8.23
Book value per share	CAD -0.03
Debt / EBITDA	17.98
Goodwill	CAD 2.2M
Interest coverage	-0.41
Long-term assets	CAD 302M
Long-term liabilities	CAD 162M
Net cash (debt)	CAD -328.1M
Net cash / market cap	-940.76%
Net debt / EBITDA	35.37
Piotroski F-Score	1
Property, plant and equipment	CAD 201.1M
Shareholders' equity	CAD -185.7M
Tangible book value	CAD -277.6M
Tangible book value per share	CAD -0.04
Total assets	CAD 367M
Total cash	CAD 11.4M
Total debt	CAD 339.5M
Total liabilities	CAD 552.7M
WACC	7.77%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	CAD 65M
Current liabilities	CAD 390.6M
Current ratio	0.17
Inventory turnover	3.19
Net working capital	CAD -42.5M
Quick ratio	0.05
Working capital	CAD -330.5M
Working capital turnover	-1.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.14%
Shareholder yield	-2.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.82%
10Y return CAGR	-46.89%
10Y total return	-99.82%
150-day SMA	CAD 0.01
1D price change	0%
1Y price change	-50%
1Y return CAGR	-50.02%
1Y total return	-50%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.01
3Y price change	-85.71%
3Y return CAGR	-47.72%
3Y total return	-85.71%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.02
52-week high date	2025-10-30
52-week low	CAD 0.01
52-week low date	2026-10-29
5Y price change	-98.04%
5Y return CAGR	-54.46%
5Y total return	-98.04%
All-time high	CAD 9.49
All-time high date	2018-09-12
All-time low	CAD 0.01
All-time low date	2024-11-06
Average true range (ATR)	CAD 0.00
Average volume	229K
Beta (1Y)	2.16
Beta (2Y)	-2.73
Beta (5Y)	-0.67
Change from 52-week high	-66.67%
Change from 52-week low	0%
Change from all-time high	-99.95%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 8.78
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	35.49
Open price	CAD 0.01
Previous close	CAD 0.01
Price vs 150-day SMA	-3.85%
Price vs 20-day SMA	-5.66%
Price vs 200-day SMA	-19.35%
Price vs 50-day SMA	-5.66%
Relative volume	0.01
RSI	46.93
Sharpe ratio	1.56
Sharpe ratio (3Y)	1.29
Sharpe ratio (5Y)	1.06
Sortino ratio	3.42
Sortino ratio (3Y)	2.55
Sortino ratio (5Y)	2.06
Volume	1.8K
Weekly RSI	46.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4B
Shares change (QoQ)	0%
Shares change (YoY)	2.14%
Shares held by insiders	3.79%
Shares outstanding	7B

Deeper analysis on CSE/IAN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/IAN report

Is a complete CSE/IAN research report available?

No complete published report is available for cse/IAN (CSE/IAN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/IAN (CSE/IAN)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/IAN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/IAN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/IAN

Frequently asked questions